DIAZOXIDE

DIAZOXIDE was reported 737 times

DIAZOXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RE-OPENING OF DUCTUS ARTERIOSUS 1 0.2000
1 INSULINOMA 22 0.1243
2 PANCREATIC ISLETS HYPERPLASIA 2 0.0952
3 BREAST MILK SUBSTITUTE INTOLERANCE 1 0.0833
4 PANCREATICOSPLENECTOMY 1 0.0769
5 CNS GERMINOMA 1 0.0625
6 HYPERINSULINAEMIC HYPOGLYCAEMIA 11 0.0495
7 ADENOVIRAL CONJUNCTIVITIS 1 0.0345
8 RENAL FUNCTION TEST 1 0.0323
9 MECONIUM ILEUS 2 0.0303
10 NEONATAL PULMONARY HYPERTENSION 1 0.0263
11 NECROLYTIC MIGRATORY ERYTHEMA 1 0.0256
12 GASTRIC HYPERMOTILITY 1 0.0250
13 PROSTATITIS ESCHERICHIA COLI 1 0.0200
14 PULMONARY ARTERIOPATHY 1 0.0200
15 RIGHT VENTRICULAR HYPERTENSION 1 0.0196
16 HYPERINSULINISM 2 0.0187
17 VIRAL TONSILLITIS 1 0.0179
18 NECROTISING ENTEROCOLITIS NEONATAL 7 0.0172
19 ELECTROCARDIOGRAM U WAVE PRESENT 1 0.0161
20 NECROTISING COLITIS 20 0.0158
21 ACQUIRED HYDROCELE 1 0.0120
22 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 13 0.0117
23 BENIGN NEOPLASM OF SPINAL CORD 1 0.0111
24 ACANTHOSIS NIGRICANS 2 0.0108
25 PANCREATECTOMY 6 0.0108
26 HEPATOBLASTOMA 1 0.0103
27 ABNORMAL CLOTTING FACTOR 2 0.0098
28 HYPERAMMONAEMIC CRISIS 1 0.0093
29 RETINOBLASTOMA 1 0.0092
30 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
31 CONGENITAL MEGACOLON 1 0.0088
32 BENIGN UTERINE NEOPLASM 1 0.0085
33 PULMONARY VEIN STENOSIS 1 0.0085
34 INSULIN AUTOIMMUNE SYNDROME 3 0.0084
35 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
36 HYPOGLYCAEMIC SEIZURE 7 0.0077
37 FEVER NEONATAL 1 0.0076
38 SOFT TISSUE NEOPLASM 1 0.0076
39 INSULIN C-PEPTIDE INCREASED 1 0.0072
40 HYPEROSMOLAR HYPERGLYCAEMIC STATE 1 0.0071
41 HYPERTRICHOSIS 13 0.0070
42 GASTROENTERITIS ROTAVIRUS 2 0.0065
43 MUCOCUTANEOUS DISORDER 1 0.0063
44 AMINO ACID LEVEL DECREASED 2 0.0059
45 COLON CANCER STAGE I 1 0.0057
46 JEJUNOSTOMY 1 0.0055
47 BLOOD ALKALINE PHOSPHATASE 1 0.0054
48 RICKETS 1 0.0053
49 EXPOSURE TO EXTREME TEMPERATURE 1 0.0052
50 ZINC DEFICIENCY 1 0.0047
51 LAPAROSCOPIC SURGERY 1 0.0046
52 PANCREATIC OPERATION 1 0.0046
53 NEUTROPENIA NEONATAL 1 0.0045
54 LAPAROTOMY 2 0.0044
55 ANAPHYLACTOID SHOCK 2 0.0043
56 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 1 0.0042
57 NEUROENDOCRINE CARCINOMA METASTATIC 1 0.0041
58 LEFT VENTRICULAR ENLARGEMENT 1 0.0039
59 OVERGROWTH BACTERIAL 1 0.0037
60 PULMONARY HYPERTENSIVE CRISIS 1 0.0037
61 PERIVENTRICULAR LEUKOMALACIA 1 0.0035
62 CARDIO-RESPIRATORY DISTRESS 1 0.0035
63 SALIVARY GLAND NEOPLASM 1 0.0035
64 AGITATED DEPRESSION 1 0.0035
65 HYPEROSMOLAR STATE 1 0.0035
66 FEBRILE CONVULSION 4 0.0033
67 HYPERINSULINAEMIA 1 0.0033
68 THERAPEUTIC EMBOLISATION 1 0.0032
69 RETROPERITONEAL ABSCESS 1 0.0032
70 BACTERIAL TRANSLOCATION 1 0.0032
71 PSEUDOCYST 1 0.0031
72 HYPOGLYCAEMIA NEONATAL 5 0.0031
73 CENTRAL HYPOTHYROIDISM 1 0.0030
74 BACTERIAL PYELONEPHRITIS 1 0.0030
75 BASAL GANGLIA INFARCTION 1 0.0029
76 GROWTH FAILURE 1 0.0029
77 NEONATAL INFECTION 1 0.0029
78 HEART RATE 1 0.0029
79 TACHYPHYLAXIS 1 0.0029
80 PANCREATIC INSUFFICIENCY 1 0.0028
81 PORTAL VENOUS GAS 1 0.0028
82 OTITIS MEDIA ACUTE 2 0.0027
83 SCAN ABNORMAL 1 0.0027
84 LUNG CYST 1 0.0025
85 TRACHEOMALACIA 1 0.0025
86 HYPOGLYCAEMIC UNCONSCIOUSNESS 5 0.0025
87 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
88 TUMOUR ASSOCIATED FEVER 1 0.0024
89 ATRIAL THROMBOSIS 5 0.0024
90 VOLUME BLOOD DECREASED 1 0.0024
91 DIABETIC HYPEROSMOLAR COMA 1 0.0023
92 PNEUMATOSIS 1 0.0022
93 FEEDING INTOLERANCE 1 0.0022
94 BONE CYST 2 0.0021
95 HYPOGLYCAEMIA 101 0.0021
96 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 1 0.0021
97 BONE MARROW DEPRESSION 2 0.0020
98 PATENT DUCTUS ARTERIOSUS 8 0.0020
99 NEONATAL RESPIRATORY FAILURE 1 0.0020
100 RIGHT ATRIAL DILATATION 1 0.0020
101 NEONATAL DISORDER 3 0.0019
102 FAECAL VOMITING 1 0.0019
103 KETOSIS 2 0.0018
104 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
105 BLOOD INSULIN INCREASED 1 0.0018
106 NAIL BED BLEEDING 1 0.0018
107 CARDIORENAL SYNDROME 1 0.0017
108 HYPOGLYCAEMIC COMA 5 0.0017
109 MOTOR DEVELOPMENTAL DELAY 1 0.0017
110 NEURODEGENERATIVE DISORDER 1 0.0016
111 HYPERVOLAEMIA 8 0.0016
112 SERUM SICKNESS-LIKE REACTION 1 0.0016
113 OEDEMA GENITAL 1 0.0016
114 PANCREATIC NEUROENDOCRINE TUMOUR 1 0.0016
115 OBSTRUCTION GASTRIC 2 0.0016
116 HIRSUTISM 2 0.0015
117 BRONCHITIS VIRAL 1 0.0015
118 HEAT ILLNESS 1 0.0015
119 CYST RUPTURE 1 0.0015
120 NEUROENDOCRINE CARCINOMA 1 0.0014
121 IMMUNE THROMBOCYTOPENIC PURPURA 4 0.0014
122 DIET REFUSAL 1 0.0014
123 CHOLANGITIS ACUTE 1 0.0013
124 GASTROINTESTINAL SURGERY 1 0.0013
125 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
126 HYPERGLYCAEMIA 46 0.0013
127 POST-TRAUMATIC NECK SYNDROME 1 0.0012
128 KETONURIA 1 0.0012
129 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
130 ADRENAL SUPPRESSION 1 0.0012
131 DEAFNESS BILATERAL 2 0.0012
132 MALIGNANT HYPERTENSION 1 0.0012
133 ABDOMINAL LYMPHADENOPATHY 1 0.0012
134 FOOD REFUSAL 1 0.0011
135 CARDIAC OUTPUT DECREASED 1 0.0011
136 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
137 RIGHT VENTRICULAR HYPERTROPHY 1 0.0011
138 PROTEIN URINE 1 0.0011
139 INTESTINAL INFARCTION 1 0.0011
140 FACIAL ASYMMETRY 1 0.0010
141 GROWTH RETARDATION 3 0.0010
142 HYPERNATRAEMIA 5 0.0010
143 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
144 VENOUS THROMBOSIS LIMB 2 0.0010
145 OLIGURIA 6 0.0010
146 SUBILEUS 2 0.0010
147 INJECTION SITE HYPERSENSITIVITY 3 0.0010
148 PERTUSSIS 1 0.0010
149 FEEDING DISORDER NEONATAL 1 0.0010
150 HYPOPERFUSION 1 0.0010
151 SYSTOLIC DYSFUNCTION 1 0.0009
152 CUSHINGOID 3 0.0009
153 PORTAL VEIN THROMBOSIS 3 0.0009
154 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
155 PULMONARY HYPERTENSION 19 0.0009
156 CRYPTORCHISM 1 0.0009
157 BLOODY DISCHARGE 1 0.0009
158 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
159 HYPOVOLAEMIC SHOCK 4 0.0008
160 FACIAL BONES FRACTURE 3 0.0008
161 LARGE INTESTINE INFECTION 1 0.0008
162 BLOOD UREA DECREASED 1 0.0008
163 AMMONIA INCREASED 4 0.0008
164 PETECHIAE 8 0.0008
165 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
166 BODY MASS INDEX INCREASED 1 0.0007
167 GLYCOSURIA 1 0.0007
168 HYPERURICAEMIA 3 0.0007
169 GENERALISED OEDEMA 9 0.0007
170 HAIR GROWTH ABNORMAL 5 0.0007
171 APPENDIX DISORDER 1 0.0007
172 BLOOD ELECTROLYTES DECREASED 1 0.0007
173 INTENSIVE CARE 1 0.0007
174 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
175 INJECTION SITE HYPOAESTHESIA 1 0.0007
176 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
177 ACUTE ABDOMEN 1 0.0007
178 NORMOCYTIC ANAEMIA 1 0.0007
179 CONJUNCTIVITIS ALLERGIC 1 0.0007
180 MARASMUS 1 0.0007
181 FUNGAEMIA 1 0.0006
182 DRUG EFFECT INCREASED 2 0.0006
183 LIVER ABSCESS 2 0.0006
184 HEPATIC NEOPLASM 2 0.0006
185 BODY TEMPERATURE DECREASED 6 0.0006
186 PANCREATIC DISORDER 3 0.0006
187 OXYGEN THERAPY 1 0.0006
188 SYSTEMIC INFECTION 1 0.0006
189 ARTHROPOD STING 1 0.0006
190 SEIZURE LIKE PHENOMENA 1 0.0006
191 FAILURE TO THRIVE 3 0.0006
192 BRONCHIOLITIS 2 0.0006
193 INDURATION 1 0.0006
194 LOBAR PNEUMONIA 1 0.0005
195 HYPERTHERMIA 4 0.0005
196 BICYTOPENIA 1 0.0005
197 DEVICE RELATED SEPSIS 1 0.0005
198 LIPIDS INCREASED 1 0.0005
199 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
200 DILATATION VENTRICULAR 1 0.0005
201 FOETAL DISTRESS SYNDROME 1 0.0005
202 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
203 METASTATIC NEOPLASM 2 0.0005
204 SUSPECTED OFF LABEL USE 2 0.0004
205 BILIRUBIN CONJUGATED INCREASED 1 0.0004
206 VARICELLA 1 0.0004
207 OXYGEN CONSUMPTION INCREASED 1 0.0004
208 LONG QT SYNDROME 1 0.0004
209 WRONG DOSE 1 0.0004
210 BRONCHITIS CHRONIC 1 0.0004
211 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
212 SMALL FOR DATES BABY 2 0.0004
213 INJECTION SITE ABSCESS 1 0.0004
214 METASTASES TO LIVER 7 0.0004
215 VASODILATATION 1 0.0004
216 METASTASES TO PERITONEUM 1 0.0004
217 DRUG TOLERANCE 2 0.0004
218 HAEMATEMESIS 10 0.0004
219 PHLEBITIS 2 0.0004
220 LACTOSE INTOLERANCE 1 0.0004
221 AORTIC ARTERIOSCLEROSIS 1 0.0004
222 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
223 BLOOD GLUCOSE ABNORMAL 7 0.0004
224 THERAPY NON-RESPONDER 17 0.0004
225 TRICUSPID VALVE INCOMPETENCE 3 0.0004
226 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
227 STEATORRHOEA 1 0.0004
228 OEDEMA 20 0.0004
229 ABDOMINAL RIGIDITY 1 0.0004
230 POLYURIA 3 0.0004
231 SKIN PLAQUE 3 0.0004
232 BLOOD GLUCOSE DECREASED 17 0.0004
233 PNEUMATOSIS INTESTINALIS 1 0.0004
234 VASCULAR GRAFT 1 0.0003
235 LUNG CANCER METASTATIC 1 0.0003
236 VOMITING PROJECTILE 1 0.0003
237 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
238 URINE OUTPUT DECREASED 3 0.0003
239 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
240 CREPITATIONS 1 0.0003
241 BLOOD CULTURE POSITIVE 1 0.0003
242 RESPIRATORY DISTRESS 9 0.0003
243 PORTAL HYPERTENSION 1 0.0003
244 SWELLING OF EYELID 2 0.0003
245 ABDOMINAL ADHESIONS 1 0.0003
246 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
247 ORTHOPNOEA 1 0.0003
248 ABSCESS 5 0.0003
249 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
250 EXPOSURE TO TOXIC AGENT 1 0.0003
251 VENTRICULAR HYPOKINESIA 1 0.0003
252 LYMPHOCYTE COUNT INCREASED 1 0.0003
253 PEPTIC ULCER 1 0.0003
254 EPILEPSY 9 0.0003
255 ECCHYMOSIS 2 0.0003
256 GRANULOMA 1 0.0003
257 CAROTID ARTERY STENOSIS 1 0.0003
258 PULMONARY TOXICITY 2 0.0003
259 HEART DISEASE CONGENITAL 1 0.0003
260 HAEMORRHAGIC DIATHESIS 1 0.0003
261 PRODUCT SUPPLY ISSUE 2 0.0003
262 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
263 FLUID OVERLOAD 4 0.0003
264 CARDIOMYOPATHY 4 0.0003
265 HYPOPHOSPHATAEMIA 2 0.0003
266 PARANASAL SINUS DISCOMFORT 1 0.0003
267 HAEMODYNAMIC INSTABILITY 2 0.0003
268 OESOPHAGEAL DISORDER 1 0.0003
269 PERICARDIAL EFFUSION 6 0.0003
270 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
271 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
272 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
273 PROCEDURAL HAEMORRHAGE 1 0.0003
274 PULMONARY HAEMORRHAGE 2 0.0003
275 RESPIRATORY ACIDOSIS 1 0.0003
276 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
277 FUNGAL SKIN INFECTION 1 0.0002
278 ADRENAL INSUFFICIENCY 3 0.0002
279 RECURRENT CANCER 1 0.0002
280 SELF-MEDICATION 1 0.0002
281 LEG AMPUTATION 1 0.0002
282 GASTROINTESTINAL PERFORATION 1 0.0002
283 ONYCHOMADESIS 1 0.0002
284 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
285 MULTI-ORGAN FAILURE 4 0.0002
286 HEPATIC LESION 1 0.0002
287 TUMOUR LYSIS SYNDROME 2 0.0002
288 LIGAMENT RUPTURE 1 0.0002
289 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
290 CARDIAC FAILURE 18 0.0002
291 THIRST 4 0.0002
292 TACHYPNOEA 3 0.0002
293 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
294 LOCALISED OEDEMA 1 0.0002
295 YELLOW SKIN 1 0.0002
296 TIBIA FRACTURE 1 0.0002
297 HYPOCALCAEMIA 4 0.0002
298 CARDIAC TAMPONADE 1 0.0002
299 RECTAL HAEMORRHAGE 9 0.0002
300 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
301 ENTEROCOCCAL INFECTION 1 0.0002
302 GASTROENTERITIS 3 0.0002
303 OEDEMA PERIPHERAL 25 0.0002
304 HEPATOMEGALY 2 0.0002
305 INFLAMMATORY MARKER INCREASED 1 0.0002
306 PNEUMONIA ASPIRATION 5 0.0002
307 DERMATITIS EXFOLIATIVE 1 0.0002
308 CORONARY ARTERY STENOSIS 1 0.0002
309 HYPOXIA 7 0.0002
310 DYSLIPIDAEMIA 1 0.0002
311 PANCYTOPENIA 11 0.0002
312 FLUID RETENTION 10 0.0002
313 HYPONATRAEMIA 11 0.0002
314 FEMORAL NECK FRACTURE 1 0.0002
315 PRODUCT COLOUR ISSUE 1 0.0002
316 CACHEXIA 1 0.0002
317 CEREBRAL ISCHAEMIA 1 0.0002
318 RESPIRATORY FAILURE 14 0.0002
319 MALABSORPTION 1 0.0002
320 DRUG INTERACTION 30 0.0002
321 METABOLIC ACIDOSIS 6 0.0002
322 CARDIAC FAILURE CONGESTIVE 15 0.0002
323 INTESTINAL RESECTION 1 0.0002
324 PRODUCT PRESCRIBING ISSUE 4 0.0002
325 HYDROCEPHALUS 1 0.0002
326 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
327 VENTRICULAR FIBRILLATION 2 0.0002
328 INTRACRANIAL PRESSURE INCREASED 1 0.0002
329 BLOOD UREA INCREASED 3 0.0002
330 CHOLECYSTITIS ACUTE 1 0.0002
331 CIRCULATORY COLLAPSE 3 0.0002
332 BLOOD URIC ACID INCREASED 1 0.0002
333 NEEDLE ISSUE 5 0.0002
334 HYPERTRIGLYCERIDAEMIA 1 0.0002
335 HYPERCHLORHYDRIA 1 0.0002
336 TREATMENT FAILURE 14 0.0002
337 HEPATIC FAILURE 5 0.0002
338 INGUINAL HERNIA 1 0.0002
339 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
340 NO THERAPEUTIC RESPONSE 2 0.0002
341 RESPIRATORY DEPRESSION 2 0.0002
342 CARDIOMEGALY 2 0.0002
343 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
344 THROMBOCYTOPENIA 18 0.0002
345 CHOLESTASIS 3 0.0002
346 HAEMOGLOBIN ABNORMAL 1 0.0002
347 HAEMATOMA 4 0.0002
348 CHOLELITHIASIS 5 0.0002
349 SEPSIS 17 0.0002
350 CARDIAC FAILURE ACUTE 1 0.0001
351 MENINGITIS 1 0.0001
352 POSTOPERATIVE WOUND INFECTION 1 0.0001
353 BODY TEMPERATURE INCREASED 3 0.0001
354 ONYCHOCLASIS 1 0.0001
355 WOUND 4 0.0001
356 DUODENAL ULCER 1 0.0001
357 METASTASIS 1 0.0001
358 CONVULSION 8 0.0001
359 MYELOSUPPRESSION 5 0.0001
360 THERAPY CESSATION 7 0.0001
361 SENSITIVE SKIN 1 0.0001
362 MEDICAL DEVICE COMPLICATION 1 0.0001
363 TACHYCARDIA 12 0.0001
364 KETOACIDOSIS 1 0.0001
365 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
366 PRODUCT AVAILABILITY ISSUE 3 0.0001
367 PROCEDURAL COMPLICATION 1 0.0001
368 RENAL FAILURE CHRONIC 1 0.0001
369 CONCUSSION 1 0.0001
370 APHTHOUS ULCER 1 0.0001
371 EJECTION FRACTION DECREASED 2 0.0001
372 THERAPY PARTIAL RESPONDER 2 0.0001
373 GASTROINTESTINAL INFLAMMATION 1 0.0001
374 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
375 CYANOSIS 2 0.0001
376 BLOOD ALBUMIN DECREASED 1 0.0001
377 DRUG INTOLERANCE 12 0.0001
378 RHINITIS 1 0.0001
379 POST PROCEDURAL INFECTION 1 0.0001
380 HYPERAESTHESIA 1 0.0001
381 DRUG LEVEL INCREASED 2 0.0001
382 BLOOD PRESSURE DECREASED 8 0.0001
383 EPISTAXIS 9 0.0001
384 CARDIO-RESPIRATORY ARREST 5 0.0001
385 ATRIAL SEPTAL DEFECT 1 0.0001
386 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
387 FACE OEDEMA 2 0.0001
388 NEUTROPENIA 16 0.0001
389 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
390 VITAMIN D DECREASED 1 0.0001
391 MYOPATHY 1 0.0001
392 MUSCLE STRAIN 1 0.0001
393 PYELONEPHRITIS 1 0.0001
394 BLOOD CALCIUM INCREASED 1 0.0001
395 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
396 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
397 PURPURA 1 0.0001
398 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
399 RESPIRATORY RATE INCREASED 1 0.0001
400 CARDIOTOXICITY 1 0.0001
401 DRY MOUTH 9 0.0001
402 DEVELOPMENTAL DELAY 1 0.0001
403 LEUKOCYTOSIS 2 0.0001
404 OPTIC NEURITIS 1 0.0001
405 HIDRADENITIS 1 0.0001
406 PNEUMONIA BACTERIAL 1 0.0001
407 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
408 UROSEPSIS 1 0.0001
409 IRON DEFICIENCY ANAEMIA 1 0.0001
410 HYPOKALAEMIA 5 0.0001
411 HEPATIC FUNCTION ABNORMAL 4 0.0001
412 HEPATIC ENCEPHALOPATHY 1 0.0001
413 NEPHROPATHY 1 0.0001
414 ARTERIOSCLEROSIS 1 0.0001
415 BLOOD SODIUM DECREASED 2 0.0001
416 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
417 FRACTURE 2 0.0001
418 ABDOMINAL DISTENSION 11 0.0001
419 DIABETES MELLITUS 8 0.0001
420 DRUG PRESCRIBING ERROR 2 0.0001
421 HYPERCHOLESTEROLAEMIA 1 0.0001
422 ATELECTASIS 1 0.0001
423 VITAMIN D DEFICIENCY 1 0.0001
424 DRUG INEFFECTIVE 134 0.0001
425 HYPOTHERMIA 1 0.0001
426 TASTE DISORDER 2 0.0001
427 SUBARACHNOID HAEMORRHAGE 1 0.0001
428 NEUTROPHIL COUNT DECREASED 4 0.0001
429 INJECTION SITE DISCOMFORT 1 0.0001
430 MOUTH ULCERATION 2 0.0001
431 RENAL PAIN 1 0.0001
432 HYPOTHYROIDISM 3 0.0001
433 EATING DISORDER 2 0.0001
434 LIVER FUNCTION TEST INCREASED 2 0.0001
435 DISEASE PROGRESSION 11 0.0001
436 DECREASED ACTIVITY 1 0.0001
437 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
438 TREATMENT NONCOMPLIANCE 5 0.0001
439 ASPIRATION 1 0.0001
440 BLOOD GLUCOSE FLUCTUATION 1 0.0001
441 RENAL FAILURE 12 0.0001
442 FOOT DEFORMITY 1 0.0001
443 TRANSAMINASES INCREASED 2 0.0001
444 MALNUTRITION 1 0.0001
445 PULMONARY OEDEMA 4 0.0001
446 NEPHROPATHY TOXIC 1 0.0001
447 INTESTINAL PERFORATION 1 0.0001
448 BLOOD CALCIUM DECREASED 1 0.0001
449 MITRAL VALVE INCOMPETENCE 1 0.0001
450 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
451 MYOCARDIAL ISCHAEMIA 1 0.0001
452 DERMATITIS CONTACT 1 0.0001
453 NEOPLASM 1 0.0001
454 METASTASES TO LUNG 1 0.0001
455 CAESAREAN SECTION 1 0.0001
456 PLATELET COUNT DECREASED 9 0.0001
457 DISEASE RECURRENCE 4 0.0001
458 HYPERLIPIDAEMIA 1 0.0001
459 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
460 OFF LABEL USE 73 0.0001
461 RENAL IMPAIRMENT 7 0.0001
462 DRUG EFFECT INCOMPLETE 3 0.0001
463 C-REACTIVE PROTEIN INCREASED 3 0.0001
464 SCHIZOPHRENIA 1 0.0001
465 CYTOPENIA 1 0.0001
466 SMALL INTESTINAL OBSTRUCTION 1 0.0001
467 PHARYNGITIS 1 0.0001
468 ILEUS 1 0.0001
469 WEIGHT INCREASED 18 0.0001
470 HAIR COLOUR CHANGES 1 0.0001
471 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
472 ANOREXIA 1 0.0001
473 HIATUS HERNIA 1 0.0001
474 BEDRIDDEN 1 0.0001
475 ORAL CANDIDIASIS 1 0.0001
476 ANKYLOSING SPONDYLITIS 1 0.0001
477 PULMONARY CONGESTION 1 0.0001
478 ABNORMAL BEHAVIOUR 3 0.0001
479 MALIGNANT MELANOMA 1 0.0001
480 QUALITY OF LIFE DECREASED 1 0.0001
481 PRODUCT TASTE ABNORMAL 1 0.0001
482 PNEUMONITIS 2 0.0001
483 DRUG TOXICITY 1 0.0001
484 APPLICATION SITE RASH 1 0.0001
485 HEPATOCELLULAR INJURY 1 0.0001
486 LETHARGY 4 0.0001
487 SEIZURE 8 0.0001
488 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
489 ASCITES 2 0.0001
490 BRONCHITIS 5 0.0001
491 GASTROINTESTINAL DISORDER 6 0.0001
492 IRRITABILITY 4 0.0001
493 OSTEOPENIA 1 0.0001
494 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
495 EMOTIONAL DISORDER 2 0.0001
496 MUSCULOSKELETAL CHEST PAIN 1 0.0001
497 FEMUR FRACTURE 2 0.0001
498 BRAIN FOG 1 0.0001
499 PNEUMOTHORAX 1 0.0001
500 RESPIRATORY TRACT CONGESTION 1 0.0001
501 ULCER 1 0.0001
502 OBESITY 1 0.0001
503 CONDITION AGGRAVATED 19 0.0001
504 HIP FRACTURE 2 0.0001
505 METASTASES TO BONE 1 0.0001
506 EYE DISORDER 2 0.0001
507 STAPHYLOCOCCAL INFECTION 2 0.0001
508 PHOTOSENSITIVITY REACTION 1 0.0001
509 FEBRILE NEUTROPENIA 4 0.0001
510 EXPIRED PRODUCT ADMINISTERED 2 0.0001
511 PERICARDITIS 1 0.0001
512 PRODUCT USE ISSUE 11 0.0001
513 HAEMATURIA 2 0.0001
514 BLOOD GLUCOSE INCREASED 11 0.0001
515 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
516 DEVICE DEFECTIVE 1 0.0001
517 ANAEMIA 11 0.0001
518 LOCAL SWELLING 1 0.0001
519 RASH MACULAR 2 0.0001
520 INTENTIONAL PRODUCT MISUSE 5 0.0001
521 BRADYCARDIA 3 0.0001
522 GASTROENTERITIS VIRAL 1 0.0001
523 BONE DISORDER 1 0.0001
524 END STAGE RENAL DISEASE 1 0.0001
525 ACCIDENTAL OVERDOSE 2 0.0001
526 DYSGEUSIA 4 0.0001
527 MIDDLE INSOMNIA 1 0.0001
528 INTESTINAL OBSTRUCTION 2 0.0001
529 GASTRIC ULCER 1 0.0001
530 DEHYDRATION 7 0.0001
531 POST PROCEDURAL COMPLICATION 1 0.0001
532 ACUTE RESPIRATORY FAILURE 1 0.0001
533 CHOKING 1 0.0001
534 SKIN FISSURES 1 0.0001
535 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
536 BLOOD PRESSURE ABNORMAL 1 0.0001
537 WEIGHT DECREASED 14 0.0001
538 FULL BLOOD COUNT DECREASED 1 0.0000
539 PRODUCT ADMINISTRATION ERROR 1 0.0000
540 STOMATITIS 3 0.0000
541 PNEUMONIA 16 0.0000
542 VERTIGO 3 0.0000
543 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
544 RIB FRACTURE 1 0.0000
545 INFECTION 7 0.0000
546 INTENTIONAL DRUG MISUSE 1 0.0000
547 DERMATITIS 1 0.0000
548 RENAL FAILURE ACUTE 2 0.0000
549 RHINORRHOEA 3 0.0000
550 BALANCE DISORDER 4 0.0000
551 FAECES DISCOLOURED 1 0.0000
552 SEPTIC SHOCK 2 0.0000
553 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
554 ACUTE KIDNEY INJURY 7 0.0000
555 MELAENA 1 0.0000
556 LIVER DISORDER 2 0.0000
557 HYPOTENSION 9 0.0000
558 PANCREATITIS ACUTE 1 0.0000
559 HEART RATE IRREGULAR 1 0.0000
560 SHOCK 1 0.0000
561 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
562 CHILLS 5 0.0000
563 VOMITING 20 0.0000
564 THERAPY INTERRUPTED 3 0.0000
565 DIABETIC KETOACIDOSIS 1 0.0000
566 HEPATIC CANCER 1 0.0000
567 PRESYNCOPE 1 0.0000
568 URINARY TRACT INFECTION 7 0.0000
569 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
570 CELLULITIS 2 0.0000
571 ABDOMINAL PAIN LOWER 1 0.0000
572 CARDIOVASCULAR DISORDER 1 0.0000
573 HEPATITIS 1 0.0000
574 FALL 13 0.0000
575 LOSS OF CONSCIOUSNESS 5 0.0000
576 HAEMOGLOBIN DECREASED 4 0.0000
577 DRUG RESISTANCE 1 0.0000
578 UNRESPONSIVE TO STIMULI 1 0.0000
579 RASH GENERALISED 1 0.0000
580 DIPLOPIA 1 0.0000
581 MUCOSAL INFLAMMATION 1 0.0000
582 ARTHRITIS 3 0.0000
583 GASTRITIS 1 0.0000
584 PANCREATITIS 2 0.0000
585 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
586 EAR INFECTION 1 0.0000
587 PYREXIA 13 0.0000
588 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
589 BLOOD BILIRUBIN INCREASED 1 0.0000
590 LIMB INJURY 1 0.0000
591 RESPIRATORY ARREST 1 0.0000
592 TREMOR 6 0.0000
593 DIZZINESS 18 0.0000
594 MENTAL STATUS CHANGES 1 0.0000
595 MEDICATION ERROR 2 0.0000
596 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
597 INFLUENZA 4 0.0000
598 ALOPECIA 7 0.0000
599 OXYGEN SATURATION DECREASED 2 0.0000
600 FLATULENCE 2 0.0000
601 HYPERSOMNIA 1 0.0000
602 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
603 DECREASED APPETITE 8 0.0000
604 LIVER FUNCTION TEST ABNORMAL 1 0.0000
605 BONE PAIN 2 0.0000
606 RESPIRATORY DISORDER 1 0.0000
607 PREMATURE BABY 1 0.0000
608 JOINT SWELLING 4 0.0000
609 HYPERTENSION 7 0.0000
610 ILL-DEFINED DISORDER 2 0.0000
611 PLEURAL EFFUSION 2 0.0000
612 EXPOSURE DURING PREGNANCY 2 0.0000
613 NERVOUS SYSTEM DISORDER 1 0.0000
614 DYSPHAGIA 3 0.0000
615 HEAD INJURY 1 0.0000
616 GAIT DISTURBANCE 6 0.0000
617 HYPERHIDROSIS 4 0.0000
618 NIGHT SWEATS 1 0.0000
619 LACTIC ACIDOSIS 1 0.0000
620 SWELLING FACE 2 0.0000
621 PRODUCT DOSE OMISSION 2 0.0000
622 BLOOD CREATININE INCREASED 2 0.0000
623 DYSPEPSIA 3 0.0000
624 OSTEONECROSIS 1 0.0000
625 HEART RATE INCREASED 3 0.0000
626 VIRAL INFECTION 1 0.0000
627 NEOPLASM MALIGNANT 2 0.0000
628 GAIT INABILITY 1 0.0000
629 FLUSHING 3 0.0000
630 ASTHENIA 11 0.0000
631 ABDOMINAL PAIN UPPER 6 0.0000
632 GASTRIC DISORDER 1 0.0000
633 VISION BLURRED 4 0.0000
634 NAUSEA 23 0.0000
635 NEOPLASM PROGRESSION 1 0.0000
636 HYPERKALAEMIA 1 0.0000
637 HEART RATE DECREASED 1 0.0000
638 SLEEP DISORDER 2 0.0000
639 LYMPHADENOPATHY 1 0.0000
640 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
641 CRYING 1 0.0000
642 DYSARTHRIA 1 0.0000
643 DYSPNOEA 15 0.0000
644 ACNE 2 0.0000
645 BLOOD PRESSURE INCREASED 4 0.0000
646 INJECTION SITE PAIN 8 0.0000
647 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
648 BACK PAIN 6 0.0000
649 ABDOMINAL PAIN 6 0.0000
650 DEATH 22 0.0000
651 FEELING ABNORMAL 6 0.0000
652 CONFUSIONAL STATE 4 0.0000
653 PSORIATIC ARTHROPATHY 1 0.0000
654 DYSKINESIA 1 0.0000
655 OSTEOPOROSIS 1 0.0000
656 VISUAL IMPAIRMENT 3 0.0000
657 ROAD TRAFFIC ACCIDENT 1 0.0000
658 DIARRHOEA 15 0.0000
659 DEVICE LEAKAGE 1 0.0000
660 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
661 COVID-19 4 0.0000
662 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
663 THROAT IRRITATION 1 0.0000
664 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
665 NEPHROLITHIASIS 1 0.0000
666 ADVERSE EVENT 2 0.0000
667 NASOPHARYNGITIS 4 0.0000
668 COUGH 6 0.0000
669 ARRHYTHMIA 1 0.0000
670 COMA 1 0.0000
671 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
672 CONTUSION 2 0.0000
673 INTERSTITIAL LUNG DISEASE 1 0.0000
674 ATRIAL FIBRILLATION 2 0.0000
675 LEUKOPENIA 1 0.0000
676 SOMNOLENCE 4 0.0000
677 SINUSITIS 2 0.0000
678 PERIPHERAL SWELLING 3 0.0000
679 ILLNESS 2 0.0000
680 INFLAMMATION 1 0.0000
681 NERVOUSNESS 1 0.0000
682 ECZEMA 1 0.0000
683 DERMATITIS ATOPIC 1 0.0000
684 DRUG EFFECT DECREASED 1 0.0000
685 OVERDOSE 4 0.0000
686 HAEMATOCHEZIA 1 0.0000
687 NECK PAIN 1 0.0000
688 PRODUCT SUBSTITUTION ISSUE 1 0.0000
689 DYSPHONIA 1 0.0000
690 PALPITATIONS 2 0.0000
691 NASAL CONGESTION 1 0.0000
692 WHEEZING 1 0.0000
693 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
694 THERAPEUTIC RESPONSE DECREASED 1 0.0000
695 DISCOMFORT 1 0.0000
696 MUSCLE SPASMS 3 0.0000
697 FEELING HOT 1 0.0000
698 INJECTION SITE ERYTHEMA 2 0.0000
699 RASH 7 0.0000
700 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
701 PRODUCT QUALITY ISSUE 2 0.0000
702 HEPATIC ENZYME INCREASED 1 0.0000
703 ERYTHEMA 3 0.0000
704 MEMORY IMPAIRMENT 2 0.0000
705 HEADACHE 9 0.0000
706 BURNING SENSATION 1 0.0000
707 DEVICE MALFUNCTION 1 0.0000
708 FATIGUE 11 0.0000
709 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
710 ANXIETY 4 0.0000
711 HALLUCINATION 1 0.0000
712 HOT FLUSH 1 0.0000
713 UNEVALUABLE EVENT 1 0.0000
714 INCORRECT DOSE ADMINISTERED 3 0.0000
715 INJECTION SITE SWELLING 1 0.0000
716 PAIN 8 0.0000
717 HOSPITALISATION 2 0.0000
718 INJECTION SITE HAEMORRHAGE 1 0.0000
719 PROSTATE CANCER 1 0.0000
720 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
721 INFLUENZA LIKE ILLNESS 1 0.0000
722 CARDIAC ARREST 1 0.0000
723 ABDOMINAL DISCOMFORT 2 0.0000
724 TOXICITY TO VARIOUS AGENTS 2 0.0000
725 SKIN EXFOLIATION 1 0.0000
726 MYALGIA 2 0.0000
727 PRODUCT STORAGE ERROR 1 0.0000
728 INSOMNIA 3 0.0000
729 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
730 ADVERSE DRUG REACTION 1 0.0000
731 NO ADVERSE EVENT 2 0.0000
732 OROPHARYNGEAL PAIN 1 0.0000
733 CHEST PAIN 2 0.0000
734 CARDIAC DISORDER 1 0.0000
735 SWELLING 1 0.0000
736 PULMONARY EMBOLISM 1 0.0000
737 SYNCOPE 1 0.0000
738 CHEST DISCOMFORT 1 0.0000
739 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
740 ARTHRALGIA 4 0.0000
741 CONSTIPATION 2 0.0000
742 ASTHMA 1 0.0000
743 MUSCULAR WEAKNESS 1 0.0000
744 DEPRESSION 2 0.0000
745 PRURITUS 3 0.0000
746 DRY SKIN 1 0.0000
747 MALAISE 3 0.0000
748 PRODUCT DOSE OMISSION ISSUE 2 0.0000
749 HYPOAESTHESIA 1 0.0000
750 DRUG DEPENDENCE 1 0.0000
751 DRUG DOSE OMISSION 1 0.0000
752 URTICARIA 1 0.0000
753 MYOCARDIAL INFARCTION 1 0.0000
754 HYPERSENSITIVITY 1 0.0000